OmnisChart
PrivateLast Round
Accelerator
Jun 1, 2024
Total Funding Raised
$220,000
Company Overview
OmnisChart operates in Healthcare & Life Sciences. Its latest recorded funding round was an Accelerator round in June 2024.
OmnisChart is a biotechnology company that provides a multi-omics, cancer biomarker discovery platform for translational researchers.
Sector
Healthcare & Life Sciences
Verticals
EHR & EMR, Vertical SaaS, Revenue Cycle
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OmnisChart Comparables
Compare OmnisChart with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RxNT | 79% | |
| OmniMD | 79% | |
| CharmHealth | 78% |
For institutional investors. Book with your work email.
OmnisChart Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 1, 2024 | ||||
| Accelerator | Oct 9, 2023 | ||||
| Grant | Dec 1, 2022 |
For institutional investors. Book with your work email.
OmnisChart Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Techstars | Accelerator |
| PharmStars | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2024
$100K raised from PharmStars
- Oct 9, 2023
$120K round led by Techstars.
For institutional investors. Book with your work email.
OmnisChart Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OmnisChart's valuation, stock price, and market status.
Is OmnisChart a public or private company?
OmnisChart is a private company.
What is the current stock price of OmnisChart?
OmnisChart is a private company, so its shares have no public market price. Caplight tracks OmnisChart's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OmnisChart worth (valuation)?
Valuation information for OmnisChart is not publicly available.
Can I buy OmnisChart stock?
OmnisChart shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OmnisChart's last funding round?
OmnisChart's most recent funding round was Accelerator on June 1, 2024.
Who are the main investors in OmnisChart?
Key investors in OmnisChart include Techstars, PharmStars.
Will OmnisChart IPO soon?
No public IPO plans have been announced for OmnisChart.
How can I track OmnisChart secondary market activity?
Caplight tracks bids, offers, and trades in OmnisChart's shares on secondary markets.